CM
ZVSAW

Cohanzick Management’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

Cohanzick Management’s Portfolio ZVSAW Stock Details ZVSAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-525,000
Closed -$90K – 508
2022
Q1 		$90K Buy
+525,000
New +$90K 0.02% 254